Acute coronary syndromes usually develop owing to the obstruction of coronary blood flow by a thrombus on a ruptured atherosclerotic plaque (1). Maintenance of coronary blood flow by removal of thrombus has been one of the most important issues of clinical cardiology. In acute coronary syndromes percutaneous transluminal coronary angioplasty (PTCA) and stenting have a higher rate of reperfusion and thus lower mortality and morbidity rates than pharmacologic treatment modalities (2-4). However, PTCA and stenting also carry the risks of distal capillary bed migration of thrombus, obstruction of microvascular circulation, and no-reflow phenomenon (5,6). This may limit the size of myocardium that survives and lead to progressive left ventricular dysfunction (7) .
conventional methods on epicardial flow and angiographic microvascular functions in patients who have undergone primary percutaneous intervention and had intracoronary thrombus.
PATIENTS AND METHODS
Twenty-nine patients who underwent primary percutaneous intervention for acute coronary syndrome and were found to have intracoronary thrombus and thrombolysis in myocardial infarc-tion (TIMI) flow value of 0-1 were included into the study. Thrombectomy and coronary stenting were applied to 14 patients. Conventional PTCA and coronary stenting were applied to the other 15 patients.
The diagnosis of myocardial infarction with ST elevation was based on the presence of chest pain longer than 30 minutes and ST elevation greater than 1 mm in 12-lead ECG. CK-MB and Troponin-T levels were above the normal limits in all of the patients. Patients with unstable angina were included into the study if there were at- 
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tacks of rest angina and ST segment and T wave changes in the ECG. All the patients were given unfractionized heparin, aspirin, beta-blocker, and nitroglycerin unless contraindicated. Heparin infusion was continued for 12-24 hours following intervention and activated partial thromboplastin time (aPTT) levels were twofold higher than normal. After the intervention, 300 mg of clopidogrel was given as a bolus and 75 mg clopidogrel per day was planned to be given for the next month. The use of glycoprotein IIb/IIIa was up to the physician's own decision according to the clinical and angiographic findings of the patients. Coronary angiographic findings were determined by two investigators. Epicardial flow before and after the intervention was evaluated by TIMI flow values (8) . Microvascular circulation was evaluated according to myocardial blush and myocardial dye intensity . The scoring system reported by van't Hof et al was used (9) .
Statistical Analysis
Patients' data were presented with descriptive statistics as frequencies and as means ± standard deviation. All statistical analyses were performed by a computer using the SPSS V10.0 system (Statistical Package for the Social Sciences INC., Chicago, USA). Evaluated variables were gender, age, type of acute coronary syndrome, anatomic location of thrombus, TIMI flow and myocardial blush grade before and after procedure, stent implantation, complications, and tirofiban infusion.
Differences in normally distributed continuous variables were tested by an unpaired Student's t test. The Mann-Whitney U test was used to compare abnormally distributed continuous variables. Categorical data were compared with a χ 2 test and Fisher's exact test for expected count <5. In all tests a p value of <0.05 was considered statistically significant.
RESULTS
The mean age of the 29 patients was 55.94 ± 11.14 year, and 22 of the patients were male (76%). Among 14 patients who had undergone thrombectomy, in only one patient was the procedure suboptimally performed owing to tortuous coronary anatomy. Stent implantation was performed to all of the patients in both groups. The basic characteristics of the patients are shown in Table 1 , and there were no significant differences between the groups. In none of the patients were severe cardiovascular side effects such as mortality, Q-wave myocardial infarction, or urgent surgical intervention encountered.
In the thrombectomy group, mean stenosis percentage before the procedure was 97.4 % ± 3.8 and mean TIMI flow was 0.8 ± 0.9. Following X-sizer thrombectomy, mean stenosis percentage decreased to 75.7% ± 15.9 (p<0.001) and mean TIMI flow value increased to 2.4 ± 0.6 (p<0.001) ( Table 2) . After thrombectomy, in 71.4% of the patients TIMI 3 epicardial flow was obtained. Stent implantation was performed in all patients and mean percentage of residual stenosis was 5.4% ± 6.3 (p<0.001). Mean diameter of the stents applied was 3.5 ± 0.4 mm and mean length was 18.8 ± 5.6 mm. Mean myocardial blush grade (MBG) was 0.7 ± 0.7 before thrombectomy and 2.6 ± 0.6 after thrombectomy (p<0.001). In 64.3% of the patients MBG 3 was obtained, indicating a significant increase in both epicaridal blood flow and myocardial tissue perfusion ( Table 2 ). In the conventional primary PTCA and stenting group, mean stenosis percentage before the procedure was 99.45% ± 1.5 and mean TIMI flow was 0.36 ± 0.81. Following PTCA and stenting, mean percentage of residual stenosis was 3.18 % ± 6.43 (p<0.001) and mean TIMI flow value increased to 2.73 ± 0.47 (p<0.001). After conventional method, in 73% of the patients TIMI 3 epicardial flow was obtained. Mean myocardial blush grade was 0.27 ± 0.65 before the procedure and significantly increased to 2.36 ± 0.67 after the procedure (p<0.001) ( Table 2 ). In 45% of the patients MBG 3 was obtained. Mean diameter of the stents applied was 2.91 ± 0.48 mm and mean length was 23.55 ± 9.45 mm. The diameters of the stents used in the conventional method were significantly smaller than those of the stents used in the thrombectomy group (p=0.007).
The coronary perfusion parameters of the two groups were compared and there were no significant difference between the TIMI flow values and MBG values (p=0.11 and p=0.44, respectively) ( Table 2 ). The effects of GP IIb/IIIa inhibitor (tirofiban) use on epicardial flow and microvascular function were determined; in 76.4% of the patients who had tirofiban infusion, TIMI 3 flow was obtained, whereas 62.5% of the patients who did not have tirofiban infusion had TIMI 3 flow (p=0.64). Similarly, MBG 3 was obtained in 52.9% of the patients who had tirofiban infusion and in 62.5% of the patients who did not have tirofiban infusion (p=0.99).
DISCUSSION
Primary PTCA, used in acute myocardial infarction for 20 years, decreases mortality and morbidity rates significantly more than thrombolytic treatment (10, 11) . However, distal embolization and no-reflow still might cause a problem. Direct stent implantation does not bring any improvement to PTCA in the prevention of distal embolization (12, 13) . Inadequate epicardial blood flow and noreflow may lead to left ventricular remodeling. This introduces the concept of removal of thrombus. TIMI 2 flow or more was maintained in 93.8% of patients who had undergone thrombectomy with Angiojet catheter, and intrahospital mortality rate was 7.1% (14) . In another study comparing the same catheter system with conventional PTCA, in the thrombectomy-applied cases, TIMI 3 flow maintenance was higher and left ventricular remodeling was prevented (15) . Another method for removal of intracoronary thrombus, X-sizer thrombectomy, is being used as an effective and safe method for restoration of coronary flow (16) (17) (18) . In a study comparing X-sizer thrombectomy applications with conventional PTCA in acute coronary syndromes, it was found that in 90% of the thrombectomy-applied patients TIMI 3 flow was maintained and epicardial flow was maintained faster compared to the control group (19) . Although epicardial flow is closely related to the progression of clinical status, it does not necessarily indicate that the microvascular circulation is adequate (20) . Mechanical reperfusion is known to cause distal macroembolization and microembolization by moving thrombus, resulting in obstruction of microvascular circulation. Slowing of distal coronary flow or no-reflow phenomenon has been reported in about one third of the patients who have undergone primary PTCA (21) .
Microvascular circulation may be determined by myocardial blush, Doppler study of coronary flow, or ST-segment resolution analysis methods. In myocardial infarction with ST elevation, STsegment resolution greater than 50% after intervention is related to more myocardial preservation and better clinical outcome (22) . Microvascular functions have been reported to be preserved more in the patients who were applied thrombectomy since early ST-segment resolution was more significant in the X-sizer thrombectomy group than in the conventional PTCA group (19) . The same study reported that coronary flow reserves by intracoronary Doppler, another indication of microvascular function, were similar in both groups.
In our study, microvascular functions were determined by myocardial blush grade. Increase in myocardial dye intensity after PTCA is associated with improvement in long-term mortality rate (9) . Although epicardial flow improved significantly in the thrombectomy-applied patients, TIMI 3 rates were similar when compared to the PTCA-applied group. However, myocardial blushing and thus microvascular functions were found better, though not statistically significant, in the X-sizer group. This statistical nonsignificance might have been due to smallsized study groups. Nevertheless, according to our and other studies' data, although thrombectomy offers additional advantages over PTCA, it cannot prevent distal embolizations completely. Thus hybrid treatment modalities, including distal protective devices and pharmacologic agents, may be a solution.
CONCLUSION
In acute coronary syndromes, use of X-sizer in addition to primary percutaneous coronary interventions is a safe method that is also partially effective in the prevention of distal embolization. We suggest that our data be supported toward further studies comparing hybrid treatment methods.
